Health knowledge made personal
Join this community!
› Share page:
Search posts:

To address ringing in the ears ...

Posted Nov 10 2008 4:23pm

To  address ringing in the ears side effect...BD

The U.S. Food and Drug Administration has approved labeling changes for erectile dysfunction (ED) drugs in the class that includes Cialis, Levitra, and Viagra, to display more prominently the potential risk of sudden hearing loss, and to guide consumers on what to do if they experience sudden problems with their hearing. In addition, the FDA plans to require the same changes in labeling for the drug Revatio, also a member of this drug class known as phosphodiesterase type 5 (PDE5) inhibitors. Revatio is used to treat pulmonary arterial hypertension (PAH). PAH is a serious medical condition in which continuous high blood pressure in arteries of the lungs weakens the heart muscle and often leads to right heart failure and death.

FDA Announces Revisions To Labels For Cialis, Levitra And Viagra

Post a comment
Write a comment: